Is Castle Biosciences, Inc. (CSTL) a Buy, Sell, or Hold?
NASDAQ : CSTL
Castle Biosciences, Inc. — Institutional Ownership
$24.545 USD
$0.04 (0.14%)
- Volume
- 129.79K
- Average Volume
- 396.08K
- Market Capitalization
- $744.45M
- P/E Ratio
- -57.15
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $44.28
- Year Low
- $14.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.75
Institutional Ownership Summary
Institutional Ownership %
1.23%
Investors Holding
16
change: -174 | last: 190
Increased Positions
8
change: -93 | last: 101
Reduced Positions
5
change: -56 | last: 61
New Positions
3
change: -25 | last: 28
Sold Positions
173
change: 135 | last: 38
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -19.3498 | last: 0.1935
Total Invested
8.39M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | RTW Investments, LP | 2.76M | 9.30% |
| 2026-05-15 | Portolan Capital Management, LLC | 1.35M | 4.45% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | RTW Investments, LP | 2.12M | 7.20% |
| 2026-01-21 | Dimensional Fund Advisors LP | 1.14M | 3.90% |
| 2025-10-09 | Dimensional Fund Advisors LP | 1.47M | 5.10% |
| 2025-05-12 | WASATCH ADVISORS LP | 998.46K | 3.50% |
| 2025-04-23 | BlackRock, Inc. | 2.34M | 8.20% |
| 2025-04-14 | Portolan Capital Management, LLC | 1.61M | 5.65% |
| 2025-01-30 | The Vanguard Group | 1.83M | 6.54% |
| 2024-02-14 | S | 2.17M | 8.05% |
| 2023-02-09 | The Vanguard Group - 23-1945930 | 1.39M | 5.29% |
| 2022-02-11 | Page 2 of 4 Pages | 1.02M | 4.00% |
| 2022-02-10 | Wasatch Advisors, Inc. 87-0319391 | 3.12M | 12.30% |
| 2022-02-04 | (1) BlackRock, Inc. | 1.8M | 7.10% |
| 2021-02-17 | Daniel Bradbury | 743.42K | 3.00% |
| 2021-02-16 | 2018, L.P. | 57599.0 | 0.20% |
| 2021-02-16 | III | 741.3K | 3.10% |
| 2021-02-17 | Derek J. Maetzold | 1.66M | 6.62% |
| 2021-02-16 | QP 2018, L.P. | 67401.0 | 0.30% |
| 2021-02-16 | 2018 GP, LLC | 125K | 0.50% |
| 2021-02-16 | 2013 GP, LLC | 503.41K | 2.10% |
| 2021-02-16 | 2013, L.P. | 501.88K | 2.10% |
| 2021-02-17 | BioBrit, LLC | 743.42K | 3.00% |
| 2021-02-12 | Industry Ventures Healthcare, LLC | 10.0 | 0.00% |
| 2021-02-12 | Industry Ventures Management VII, LLC | - | 0.00% |
| 2021-02-12 | United States of America | - | 0.00% |
| 2021-02-11 | Wasatch Advisors, Inc. 87-0319391 | 2.06M | 8.40% |
| 2021-02-10 | ARK Investment Management LLC | 2.55M | 10.44% |
| 2020-07-14 | Dr. Garheng Kong (“Kong”) | 1.18M | 6.00% |
| 2020-07-14 | HealthQuest Venture Management, L.L.C. (“HealthQuest Management”) | 1.18M | 6.00% |
| 2020-07-14 | Sofinnova HealthQuest Partners, L.P. (“HealthQuest”) | 1.18M | 6.00% |
| 2020-06-24 | Dr. Garheng Kong (“Kong”) | 1.23M | 7.20% |
| 2020-06-24 | HealthQuest Venture Management, L.L.C. (“HealthQuest Management”) | 1.23M | 7.20% |
| 2020-06-24 | Sofinnova HealthQuest Partners, L.P. (“HealthQuest”) | 1.23M | 7.20% |
| 2020-05-14 | Dr. Garheng Kong (“Kong”) | 1.43M | 8.30% |
| 2020-05-14 | Sofinnova HealthQuest Partners, L.P. (“HealthQuest”) | 1.43M | 8.30% |
| 2020-05-14 | HealthQuest Venture Management, L.L.C. (“HealthQuest Management”) | 1.43M | 8.30% |
| 2020-02-12 | Derek J. Maetzold | 1.95M | 11.30% |
| 2020-02-12 | BioBrit, LLC | 908.58K | 5.30% |
| 2020-02-12 | Daniel Bradbury | 908.58K | 5.30% |
| 2020-02-11 | 2018, L.P. | 115.3K | 0.70% |
| 2020-02-11 | 2018 GP, LLC | 250K | 1.50% |
| 2020-02-11 | 2013 GP, LLC | 1.5M | 8.80% |
| 2020-02-11 | III | 1.95M | 11.50% |
| 2020-02-11 | QP 2018, L.P. | 134.7K | 0.80% |
| 2020-02-11 | 2013, L.P. | 1.5M | 8.80% |
| 2020-02-05 | Industry Ventures Management VII, LLC | 1.25M | 7.30% |
| 2020-02-05 | Industry Ventures Healthcare, LLC | 1.25M | 7.30% |
| 2020-02-05 | Johan D. Swildens | 1.25M | 7.30% |
| 2019-08-05 | HealthQuest Venture Management, L.L.C. (“HealthQuest Management”) | 1.83M | 11.00% |
| 2019-08-05 | Sofinnova HealthQuest Partners, L.P. (“HealthQuest”) | 1.83M | 11.00% |
| 2019-08-05 | Dr. Garheng Kong (“Kong”) | 1.83M | 11.00% |
CSTL Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $38.90 | 28.99M | $1.13B | $116.73M | $36.91M | $1.05B |
| 2024-12-31 | $26.65 | 27.78M | $740.23M | $119.71M | $26.34M | $646.87M |
| 2023-12-31 | $21.58 | 26.8M | $578.39M | $98.84M | $15.34M | $494.88M |
| 2022-12-31 | $23.54 | 26.05M | $613.31M | $122.95M | $13.4M | $503.76M |
| 2021-12-31 | $42.87 | 25.14M | $1.08B | $329.63M | $8.2M | $756.19M |
| 2020-12-31 | $67.15 | 18.93M | $1.27B | $409.85M | -$ | $861.23M |
| 2019-12-31 | $34.37 | 8.58M | $295.03M | $98.84M | $25.12M | $221.31M |
| 2018-12-31 | $21.40 | 10.65M | $227.92M | $4.48M | $24.5M | $247.94M |
| 2017-12-31 | $21.40 | 9.78M | $209.38M | $1.21M | $18.6M | $226.77M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24.55 | 29.89M | $733.77M | $63.76M | $36.72M | $706.73M |
| 2025-12-31 | $38.90 | 29.33M | $1.14B | $116.73M | $36.91M | $1.06B |
| 2025-09-30 | $22.77 | 25.05M | $570.39M | $85.56M | $37.14M | $521.97M |
| 2025-06-30 | $20.42 | 28.91M | $590.42M | $82.23M | $37.35M | $545.54M |
| 2025-03-31 | $20.02 | 28.61M | $572.75M | $89.69M | $25.84M | $508.91M |
| 2024-12-31 | $26.65 | 28.13M | $749.56M | $119.71M | $26.34M | $656.19M |
| 2024-09-30 | $28.52 | 27.84M | $794M | $94.96M | $26.74M | $725.78M |
| 2024-06-30 | $21.19 | 27.65M | $585.82M | $85.57M | $25.19M | $525.44M |
| 2024-03-31 | $22.25 | 27.48M | $611.54M | $82.95M | $25.05M | $553.65M |
| 2023-12-31 | $21.58 | 27.14M | $585.76M | $98.84M | $15.34M | $502.25M |
| 2023-09-30 | $16.89 | 26.83M | $453.23M | $91.22M | $14.53M | $376.53M |
| 2023-06-30 | $13.72 | 26.73M | $366.78M | $95.87M | $14.39M | $285.3M |